SRTS News

Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, raised $11 million by offering 2 million units at $5.50. Sensus originally planned to raise $20 million in March at a market cap of $97 million, but postponed the deal. It came back in May with a new underwriter and stapled warrants at a proposed price of $6.25 ($80...read more

Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, announced terms for its IPO on Friday. The Boca Raton, FL-based company plans to raise $11 million by offering 1.8 million units at a price of $6.25, consisting of one common share and one warrant. At the midpoint of the proposed range, Sensus Healthcare would command a...read more

No companies went public during the final week of March, ending the IPO market's slowest quarter since 2009. Micro-cap systems maker Sensus Healthcare (SRTSU) postponed a $20 million IPO at a proposed $97 million market cap. However, some billion-dollar IPO news hit this week with the initial filing of AIG spinoff...read more

Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, postponed its IPO on Wednesday. It had filed to raise $20 million by offering 1.8 million shares at a price range of $10 to $12. Only eight IPOs have priced in 2016, all in the healthcare sector, thanks to significant support from insiders.  The Boca Raton,...read more